Vaccine Process Development Scientist - Fermentation Leader

elanco; Iowa City (IA); On-site; USD 130,000 - 180,000; Full time

Benefits offered by this job

Multiple relocation packages

Two weeklong shutdowns (US)

8-week parental leave

Employee Resource Groups

Annual bonus offering

Flexible work arrangements

401K matching

Job summary

Elanco is seeking a Research Scientist (R1) in Vaccine Technical Development to lead and advance R&D projects focused on fermentation and bioreactor technologies. The role spans project ownership, strategic planning, and cross-functional collaboration to drive process development and product licensure timelines.

The candidate will mentor teammates, design experiments, and oversee data interpretation while advancing scalable upstream bioprocessing capabilities and ensuring project milestones are

Qualifications

• Excellent communication and writing skills.
• Proven ability to mentor others and train teams.
• Ability to influence business decisions and drive projects.

Responsibilities

• Lead large-scale Technical Development projects in fermentation and bioreactor systems.
• Own projects or lead technical areas and guide cross-functional teams.
• Design, execute and interpret experiments and SOPs for process improvements.
• Troubleshoot and resolve complex technical issues in upstream bioprocessing.
• Provide data-driven insights to management and project teams.
• Coordinate with internal stakeholders and manage project timelines.

Skills

Leadership

Communication

Mentoring

Problem solving

Education

MS in science with >10 years experience

PhD with 1+ year experience

Job description

Elanco is seeking a Research Scientist (R1) in Vaccine Technical Development to lead and advance R&D projects focused on fermentation and bioreactor technologies. The role spans project ownership, strategic planning, and cross-functional collaboration to drive process development and product licensure timelines.

The candidate will mentor teammates, design experiments, and oversee data interpretation while advancing scalable upstream bioprocessing capabilities and ensuring project milestones are